Sign in to Administration. The default account is administrator with blank password.
Home News Latest News HPRA Drug Safety Newsletter Edition 95

HPRA Drug Safety Newsletter Edition 95

Home News Latest News HPRA Drug Safety Newsletter Edition 95
December 11, 2019

The 95th edition of the HPRA Drug Safety Newsletter

The 95th edition of the HPRA Drug Safety Newsletter includes information on the following medicines:

  • Methotrexate – New measures to avoid dosing errors 
  • SGLT2 inhibitors – Updated advice on monitoring ketone bodies in patients hospitalised for major surgical procedures or acute serious medical illnesses
  • Ingenol mebutate (Picato ) – Use with caution in patients with a history of skin cancer
  • Fingolimod (Gilenya ) – Contraindication in pregnant women and in women of child bearing potential not using effective contraception
  • Levothyroxine – Close monitoring recommended in the event of a brand change
  • Parenteral nutrition products for neonates and children below 2 years of age – Protect from light until administration is completed


The online versions of the DSN contains hyperlinks to product information and other documents on the HPRA and European Medicines Agency (EMA) websites, as appropriate.

Subscribe to our eZine

Receive our monthly newsletter with news and other content relevant to the Irish nursing and midwifery professions.